• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病中特定核型的微小RNA特征

Karyotype-specific microRNA signature in chronic lymphocytic leukemia.

作者信息

Visone Rosa, Rassenti Laura Z, Veronese Angelo, Taccioli Cristian, Costinean Stefan, Aguda Baltazar D, Volinia Stefano, Ferracin Manuela, Palatini Jeff, Balatti Veronica, Alder Hansjuerg, Negrini Massimo, Kipps Thomas J, Croce Carlo M

机构信息

Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Blood. 2009 Oct 29;114(18):3872-9. doi: 10.1182/blood-2009-06-229211. Epub 2009 Aug 28.

DOI:10.1182/blood-2009-06-229211
PMID:19717645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2773482/
Abstract

Chromosomal abnormalities, immunoglobulin heavy chain variable-region (IGHV) gene mutation status, and zeta-associated protein 70 (ZAP-70) expression levels have independent prognostic relevance in chronic lymphocytic leukemia (CLL); however, their concordance is variable. Because deregulation of microRNAs has been linked to disease initiation and progression in CLL, we studied the value of the microRNAs as a signature for CLL patients with specific chromosomal abnormalities. We identified 32 microRNAs able to discriminate the 11q deletion, 17p deletion, trisomy 12, 13q deletion, and normal karyotype cytogenetic subgroups. The expression values of 9 among the 32 microRNAs (miR-151-3p, miR-34a, miR-29c, miR-29b, miR-155, miR-148a, miR-146a, miR-146b5p, and miR-640) were correlated with gene expression data from the same samples to assess their biologic impact on CLL. In this study we also found that IGHV unmutated, high expression of ZAP-70 protein, and low expression of the miR-223, miR-29c, miR-29b, and miR-181 family were strongly associated with disease progression in CLL cases harboring 17p deletion, whereas in those harboring trisomy 12 only high expression of the miR-181a, among the analyzed parameters, suggested more aggressive disease. Thus, the use of the microRNA-based classifications may yield clinically useful biomarkers of tumor behavior in CLL.

摘要

染色体异常、免疫球蛋白重链可变区(IGHV)基因突变状态以及ζ相关蛋白70(ZAP-70)表达水平在慢性淋巴细胞白血病(CLL)中具有独立的预后相关性;然而,它们之间的一致性是可变的。由于微小RNA的失调与CLL的疾病发生和进展有关,我们研究了微小RNA作为具有特定染色体异常的CLL患者标志物的价值。我们鉴定出32种微小RNA能够区分11q缺失、17p缺失、三体12、13q缺失和正常核型细胞遗传学亚组。32种微小RNA中的9种(miR-151-3p、miR-34a、miR-29c、miR-29b、miR-155、miR-148a、miR-146a、miR-146b5p和miR-640)的表达值与来自相同样本的基因表达数据相关,以评估它们对CLL的生物学影响。在本研究中,我们还发现,在伴有17p缺失的CLL病例中,IGHV未突变、ZAP-70蛋白高表达以及miR-223、miR-29c、miR-29b和miR-181家族低表达与疾病进展密切相关,而在伴有三体12的病例中,在所分析的参数中,只有miR-181a高表达提示疾病更具侵袭性。因此,基于微小RNA的分类可能产生CLL中肿瘤行为的临床有用生物标志物。

相似文献

1
Karyotype-specific microRNA signature in chronic lymphocytic leukemia.慢性淋巴细胞白血病中特定核型的微小RNA特征
Blood. 2009 Oct 29;114(18):3872-9. doi: 10.1182/blood-2009-06-229211. Epub 2009 Aug 28.
2
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.miRNA/TP53 反馈回路与 B 细胞慢性淋巴细胞白血病发病机制和预后的关联。
JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.
3
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.miR-17∼92 家族调节未突变 IGHV 基因的 CLL 细胞对 Toll 样受体 9 触发的反应。
Leukemia. 2012 Jul;26(7):1584-93. doi: 10.1038/leu.2012.44. Epub 2012 Feb 20.
4
miR-34a as part of the resistance network in chronic lymphocytic leukemia.微小RNA-34a作为慢性淋巴细胞白血病耐药网络的一部分。
Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21.
5
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.其他遗传高危特征,如11q缺失、17p缺失和V3-21使用情况,是慢性淋巴细胞白血病中ZAP-70和VH突变状态不一致的特征。
J Clin Oncol. 2006 Feb 20;24(6):969-75. doi: 10.1200/JCO.2005.03.7184. Epub 2006 Jan 17.
6
miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.miR-34a 和 miR-29b 作为中国维吾尔族和汉族慢性淋巴细胞白血病患者无治疗生存预后的标志物。
Mol Cell Probes. 2019 Oct;47:101436. doi: 10.1016/j.mcp.2019.101436. Epub 2019 Aug 16.
7
Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.伴有11号染色体缺失和12号染色体三体异常的慢性淋巴细胞白血病患者侵袭性疾病的分子基础。
Int J Mol Med. 2007 Oct;20(4):461-9.
8
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.使用优化的流式细胞术方法对B细胞慢性淋巴细胞白血病患者ZAP-70表达的多中心研究。
Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622. Epub 2008 Jan 26.
9
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.一种与慢性淋巴细胞白血病的预后和进展相关的微小RNA特征。
N Engl J Med. 2005 Oct 27;353(17):1793-801. doi: 10.1056/NEJMoa050995.
10
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.ZAP-70表达可识别出一种慢性淋巴细胞白血病亚型,其免疫球蛋白基因未发生突变,临床预后较差,且具有独特的基因表达谱。
Blood. 2003 Jun 15;101(12):4944-51. doi: 10.1182/blood-2002-10-3306. Epub 2003 Feb 20.

引用本文的文献

1
A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中微小RNA测序数据分析实用指南
Methods Mol Biol. 2025;2883:403-426. doi: 10.1007/978-1-0716-4290-0_18.
2
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.微小RNA谱作为慢性淋巴细胞白血病首次治疗时间的预测指标:来自O-CLL1前瞻性研究的见解
Noncoding RNA. 2024 Aug 23;10(5):46. doi: 10.3390/ncrna10050046.
3
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.miR-223-3p 在癌症发生发展和癌症药物耐药中的作用:同一枚硬币,两面不同。
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
4
Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.全球 miRNA 谱分析揭示了导致亚洲和西方人群慢性淋巴细胞白血病发病率不同的关键分子。
Haematologica. 2024 Feb 1;109(2):479-492. doi: 10.3324/haematol.2023.283181.
5
Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.成熟B细胞非霍奇金淋巴瘤的基因组格局——从淋巴瘤发生到耐药性的评估
J Egypt Natl Canc Inst. 2022 Dec 12;34(1):52. doi: 10.1186/s43046-022-00154-z.
6
The Role of miR-29s in Human Cancers-An Update.miR-29s在人类癌症中的作用——最新进展
Biomedicines. 2022 Aug 29;10(9):2121. doi: 10.3390/biomedicines10092121.
7
Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.人胆汁中胆管癌的诊断生物标志物:一项基于证据的研究。
Cancers (Basel). 2022 Aug 13;14(16):3921. doi: 10.3390/cancers14163921.
8
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells.miR-146b-5p 调控慢性淋巴细胞白血病细胞中 IL-23 受体复合物的表达。
Blood Adv. 2022 Oct 25;6(20):5593-5612. doi: 10.1182/bloodadvances.2021005726.
9
Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application.循环 microRNAs 作为可靠的肿瘤生物标志物:临床应用面临的机遇与挑战。
J Pharmacol Exp Ther. 2023 Jan;384(1):35-51. doi: 10.1124/jpet.121.000896. Epub 2022 Jul 9.
10
miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.淋巴细胞白血病中的 miRNAs-耐药的 miRror。
Int J Mol Sci. 2022 Apr 22;23(9):4657. doi: 10.3390/ijms23094657.

本文引用的文献

1
MiRNAs and cancer.微小RNA与癌症。
Am J Pathol. 2009 Apr;174(4):1131-8. doi: 10.2353/ajpath.2009.080794. Epub 2009 Mar 5.
2
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.微小RNA-29b通过直接靶向DNA甲基转移酶3A和3B以及间接靶向DNA甲基转移酶1,诱导急性髓系白血病中的全基因组DNA低甲基化和肿瘤抑制基因重新表达。
Blood. 2009 Jun 18;113(25):6411-8. doi: 10.1182/blood-2008-07-170589. Epub 2009 Feb 11.
3
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.微小RNA-29c和微小RNA-223的下调在慢性淋巴细胞白血病中具有体内意义,并改善疾病风险分层。
Blood. 2009 May 21;113(21):5237-45. doi: 10.1182/blood-2008-11-189407. Epub 2009 Jan 14.
4
Most mammalian mRNAs are conserved targets of microRNAs.大多数哺乳动物的信使核糖核酸是微小核糖核酸的保守靶标。
Genome Res. 2009 Jan;19(1):92-105. doi: 10.1101/gr.082701.108. Epub 2008 Oct 27.
5
miR-34a as part of the resistance network in chronic lymphocytic leukemia.微小RNA-34a作为慢性淋巴细胞白血病耐药网络的一部分。
Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21.
6
17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.B淋巴细胞慢性淋巴细胞白血病(B-CLL)患者的17p13/TP53缺失与微小RNA-34a下调有关。
Leukemia. 2009 Mar;23(3):625-7. doi: 10.1038/leu.2008.264. Epub 2008 Sep 25.
7
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.ZAP-70、CD38及免疫球蛋白突变状态在预测慢性淋巴细胞白血病侵袭性疾病中的相对价值
Blood. 2008 Sep 1;112(5):1923-30. doi: 10.1182/blood-2007-05-092882. Epub 2008 Jun 24.
8
MicroRNA expression profiling using microarrays.使用微阵列进行微小RNA表达谱分析。
Nat Protoc. 2008;3(4):563-78. doi: 10.1038/nprot.2008.14.
9
Chronic lymphocytic leukaemia.慢性淋巴细胞白血病
Lancet. 2008 Mar 22;371(9617):1017-29. doi: 10.1016/S0140-6736(08)60456-0.
10
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.慢性淋巴细胞白血病诊断与治疗指南:慢性淋巴细胞白血病国际研讨会报告,更新美国国立癌症研究所工作组1996年指南
Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23.